Masco Group

Masco Group is a leading provider of integrated technology solutions for the Life Sciences industry, catering to a global customer base of biopharmaceutical manufacturers and CDMOs specializing in biologics, pharma, and advanced therapy medicinal products (ATMPs) such as cell & gene therapies. The company's subsidiaries, including Stilmas, Olsa, DOC, BCD, and KeyPlants, are renowned for their expertise in clean utilities, process technologies, services, and modular facility solutions. Based in Milan, Italy, Masco Group operates five production sites and three sales & services hubs across Europe, America, and Asia, serving over 6000 clients worldwide. With a legacy dating back to 1912, the company delivers approximately 300 complete projects annually, encompassing engineering, manufacturing, installation, commissioning, and after-sales services. The company's slogan, "Your technology and integration partner for manufacturing in the Life Sciences industry," reflects its commitment to being a strategic ally for its clients. Despite the absence of specific details on the last investment and associated investors, Masco Group's track record and extensive portfolio across the pharmaceutical, waste solution, and water industries position it as an attractive prospect for potential investors seeking opportunities in the Life Sciences sector. For additional information, visit the company's official websites: www.stilmas.com, www.olsa.com, www.bcd.ie, www.docvalidation.it, www.keyplants.com, www.vils.be, and www.mgautomation.com.